SOST and chronic kidney disease: According to other investigators, the rise of sclerostin in CKD patients was thought to be caused by the reduction of GFR, but the study of 120 patients with CKD proved that increased sclerostin serum levels did not result from decreased renal elimination because urinary excretion of sclerostin increased with the declining renal function [35].